We hereby report a short case of 71-year-old gentleman who developed ST segment elevation myocardial infarction shortly after starting the infusion of liposomal amphotericin B for disseminated histoplasmosis. We also discuss the novel pathogenesis of specific liposomal component of amphotericin B that contributed to the acute cardiopulmonary compromise in our patient leading to subsequent myocardial infarction.
|Original language||English (US)|
|Journal||American Journal of Therapeutics|
|State||Published - Sep 1 2011|
- liposomal amphotericin B
- myocardial infarction
ASJC Scopus subject areas
- Pharmacology (medical)